Clinical Observation and Study on the Prediction of Endometriosis by Inflammatory Immune Disease Related Genes

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400095035

Enrollment

Unknown

Registered

2024-12-31

Start date

2025-01-01

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Endometriosis experimental group (tissue samples):None

Endometriosis control group (tissue samples):None

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the experimental group: age range of 18-40 years old; No other serious health issues; Not receiving relevant treatment; Diagnose the disease Inclusion criteria for the control group: age range of 18-40 years old; No other serious health issues; Not receiving relevant treatment; Exclude the disease

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Expression levels of genes related to inflammatory and immune diseases;	—

Countries

China

Contacts

Public ContactShuguang Zhou

Linquan Maternal and Child Health Hospital.

zhoushuguang@ahmu.edu.cn+86 139 5511 7688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026